Netherlands· NL-2782d7b2c1c5

Peptonorm 1 g, tabletten

A sucralfate product containing sucralfaat x-water, registered in Netherlands by Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. The same ATC class is registered in 13 of our 19 countries.

ATC A02BX02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about sucralfaat x-waterAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Sucralfate is registered in 13 of 19 countries.

Countries holding a registration under ATC A02BX02 (sucralfate), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
7 of them publish a price we can compare per daily dose

Search sucralfate products by name

Sucralfate · ATC A02BX02

13 / 19 countries

Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Italyprice
Japan
Netherlands
Norwayprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sucralfate costs, country by country.

Normalised to the WHO defined daily dose (4 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Sucralfate · price per daily dose (4 g)

USD · FX 28 Sept 2026

IT Italy$0.62

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: SUCRALFAAT X-WATER
Manufacturer: Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A
Country: Netherlands (NL)
ATC code: A02BX02
ATC class: Sucralfate
Defined daily dose: 4 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
129675

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

504 interactions on record for sucralfate.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check sucralfate against other medicines How interaction checks work

Sucralfate · interactions on record

504 records

5 severe
116 moderate
46 minor
337 info

Most severe, free to view

ParicalcitolA11CC07severe
ParicalcitolH05BX02severe
DoxercalciferolH05BX03severe
DolutegravirJ05AJ03severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sucralfate in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sucralfate products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

Austria · Sucralan, Sucralfat Genericon
Germany · Sucrabest
Denmark · Antepsin, Peptonorm
Finland · Antepsin, Peptonorm
France · Keal, Ulcar
United Kingdom (Northern Ireland) · Sucralfate Roma Pharmaceuticals
Greece · Peptonorm
Hungary · Peptonorm
Iceland · Antepsin
Italy · Antepsin, Sucralfato Doc Generici
Norway · Antepsin
Portugal · Sucralfato Generis, Sucralfato Jaba
Sweden · Andapsin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/5e9dafb6-fb14-465a-b445-7223be2ea538
GET /v1/drugs/5e9dafb6-fb14-465a-b445-7223be2ea538?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h129675_smpc.pdf",
  "strength": null,
  "atc_label": "Sucralfate",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg129675",
  "excipients": [
    "CARMELLOSE NATRIUM (E 466)",
    "CASTOROLIE, GEHYDROGENEERD",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "MACROGOL 6000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POVIDON K 30 (E 1201)"
  ],
  "substances": [
    "SUCRALFAAT X-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h129675.pdf",
  "authorised_at": "2023/08/25",
  "procedure_number": "DK/H/3302/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "129675",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about sucralfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console